Commonalities in the time trends of Crohn's disease and ulcerative colitis

被引:1
|
作者
Delcò, F
Sonnenberg, A
机构
[1] Dept Vet Affairs Med Ctr, Albuquerque, NM 87108 USA
[2] Univ New Mexico, Albuquerque, NM 87131 USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 94卷 / 08期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: The analysis of the time trends of inflammatory bowel disease (IBD) is a powerful research tool to assess the contribution of environmental factors to its etiology and to gain insights about possible causative mechanisms. A previous study revealed a characteristic relationship between the time trends of mortality from Crohn's disease and ulcerative colitis. The present study aimed to test whether the most recent temporal patterns still corroborate the hypothesis of two interacting risk factors in the development of IBD. The time trends of IBD from six countries were checked for common features. METHODS: Mortality data from Australia, Canada, England and Wales, the Netherlands, Sweden, and the United States were analyzed. Age- and sex-specific death rates, as well as total death rates, from Crohn's disease and ulcerative colitis were plotted against the period of death. RESULTS: Mortality from ulcerative colitis decreased continuously during the past 40 years. Mortality from Crohn's disease increased between 1950 and the mid-1970's until reaching a similar level as mortality from ulcerative colitis. Since then the death rates of both diseases have followed a parallel time course. A similar behavior was found, if male and female data were analyzed separately. It could be also discerned in the time trends of each age group. The data from all six countries revealed identical temporal patterns. CONCLUSIONS: The similar time trends of IBD from differ ent countries support the hypothesis that identical causative mechanisms are responsible for the mortality and the occurrence of IBD among populations characterized by different political history and health care systems. The rapidity of the temporal changes implicates environmental agents in the etiology of both diseases. The relationships between the temporal changes of Crohn's disease and ulcerative colitis point at the existence of a shared risk factor responsible for the occurrence of both diseases, and at the existence of at least one additional factor, responsible for the expression of Crohn's disease alone. (Am J Gastroenterol 1999;94: 2171-2176. (C) 1999 by Am. Coll. of Gastroenterology).
引用
收藏
页码:2171 / 2176
页数:6
相关论文
共 50 条
  • [32] Naltrexone Therapy for Crohn's Disease and Ulcerative Colitis
    Weinstock, Leonard B.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (08) : 742 - 742
  • [33] Ulcerative colitis or Crohn's disease? Pitfalls and problems
    Feakins, Roger M.
    HISTOPATHOLOGY, 2014, 64 (03) : 317 - 335
  • [34] Aminosalicylates in the treatment of ulcerative colitis and Crohn's disease
    Sutherland, LR
    ADVANCES IN INFLAMMATORY BOWEL DISEASES, 1999, 106 : 201 - 209
  • [35] Prevalence of ulcerative colitis and Crohn’s disease in Japan
    Keiko Asakura
    Yuji Nishiwaki
    Nagamu Inoue
    Toshifumi Hibi
    Mamoru Watanabe
    Toru Takebayashi
    Journal of Gastroenterology, 2009, 44 : 659 - 665
  • [36] Biological therapy in Crohn's disease and ulcerative colitis
    Dolz, C.
    MEDICINA BALEAR, 2008, 23 (03): : 19 - 23
  • [37] Crohn's disease and ulcerative colitis: Antibodies and men
    Duclos, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (11): : 865 - 866
  • [38] The Genetics Universe of Crohn's Disease and Ulcerative Colitis
    Parkes, Miles
    DIGESTIVE DISEASES, 2012, 30 : 78 - 81
  • [39] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [40] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898